The India Hemodialysis Equipment Market was valued at $256.8 Mn in 2023 and is projected to grow at a CAGR of 10.6% from 2023 to 2023, to $519.8 Mn by 2030. The key drivers of this industry are increasing incidence of chronic kidney disease (CKD) and end-stage renal disease (ESRD), availability of advanced dialysis machines and consumables, government initiatives to improve dialysis accessibility, growing adoption of home haemodialysis, expansion of dialysis service providers which has contributed to market growth. The industry is primarily dominated by players such as Hindustan Syringes & Medical Devices Ltd, Trivitron Healthcare, Baxter, B. Braun SE, Fresenius Medical Care AG, Medtronic among others.
The India Dental Fluoride Treatment Market was valued at $275.8 Mn in 2023 and is projected to grow at a CAGR of 6.9% from 2023 to 2023, to $440 Mn by 2030. The key drivers of this industry are growing prevalence of dental caries coupled with increasing awareness regarding oral health and hygiene, increasing the intake of sugary drinks and food, projected to drive the market. Furthermore, increasing support from the government to improve access to person-cantered treatment and to advance a holistic method of oral health equity has contributed to market growth. The industry is primarily dominated by players such as Colgate, Clove Dental, Himalayas, Dabur and Hindustan Unilever Limited among others.
The India Financial Assistance Programs Market was valued at $515.4 Mn in 2023 and is projected to grow at a CAGR of 17.6% from 2023 to 2023, to $1,603.2 Mn by 2030. The market is driven by various sector such as rising drug cost, complex insurance landscape, regulatory environment, market competition, patient adherence concern etc. The prominent pharmaceutical companies providing financial assistance to patient are such as Cipla, Dr Reddy’s, Sanofi, Merck, GSK, Johnson & Johnson, Novartis among others.
The India Periodontal Therapeutics Market was valued at $15.9 Mn in 2023 and is predicted to grow at a CAGR of 10.2% from 2023 to 2030, to $31.3 Mn by 2030. India Periodontal Therapeutics Market is growing due to Increasing disposable income and healthcare expenditure, Growing dental tourism, and Technological Advancements. The market is primarily dominated by players such as Sun Pharmaceutical Industries Ltd, Cipla, Pfizer Inc., Lupin Ltd, Teva Pharmaceuticals USA, and Bausch Health Companies Inc.
The India Biobanks Market was valued at $1,395.59 Mn in 2023 and is predicted to grow at a CAGR of 11.80% from 2023 to 2030, to $3,046.85 Mn by 2030. The key drivers of this industry include government support, the rising prevalence of chronic disease, and advancements in personalized medicine. The industry is primarily dominated by players such as Thermo Fisher Scientific, Merck KGaA, QIAGEN, and Hamilton Company among others.
The India Radiology Service Market was valued at $72.7 Mn in 2023 and is predicted to grow at a CAGR of 17.7% from 2023 to 2030, to $277.6 Mn by 2030. The key drivers of the market include increasing burden of chronic diseases, aging population, and technological advancements. The prominent players of the India Radiology Service Market are Gleneagles Global Hospital, BLK Super Specialty Hospital, Apollo Hospitals, Tata Memorial Hospital, and Fortis Hospital, among others.
The India MRI Market was valued at $120.76 Mn in 2023 and is predicted to grow at a CAGR of 9.5% from 2023 to 2030, to $227.93 Mn by 2030. The key drivers of this industry the growing prevalence of chronic diseases, advanced MRI systems, and expanding healthcare infrastructure. The key players in the industry are Siemens Healthcare, Neusoft India, Voxelgrids Innovations, and Philips India among others.
The India Hypersomnia Therapeutics Market was valued at $34.50 Mn in 2023 and is predicted to grow at a CAGR of 4.75% from 2023 to 2030, to $47.74 Mn by 2030. The key drivers of this industry include increasing awareness, lifestyle changes, expanding geriatric population, and early detection. The key players in the industry are Cipla, Lupin, Abbott India, Teva Pharmaceuticals, and Jazz Pharmaceuticals among others.
India Dental Implant Market was valued at $90.80 Mn in 2023 and is predicted to grow at a CAGR of 12.8% from 2023 to 2030, to $210.90 Mn by 2030. The key drivers of this industry are a growing geriatric population, improved dental infrastructure, and increasing demand for cosmetic dentistry. The industry is primarily dominated by Straumann Group, Dentsply Sirona, Zimmer Biomet Ltd, and Henry Schein Holdings Ltd among others.
The India Head and Neck Cancer Therapeutics Market was valued at $18.30 Mn in 2023 and is predicted to grow at a CAGR of 12.75% from 2023 to 2030, to $42.39 Mn by 2030. The key drivers of this industry include rising incidence, increasing medical tourism, and advancement in treatment. The industry is primarily dominated by players such as Bristol Myers Squibb, Merck, Roche, and Pfizer among others.
The India PET Scan Market was valued at $35.3 Mn in 2023 and is predicted to grow at a CAGR of 8.4% from 2023 to 2030, to $62 Mn by 2030. The key drivers of the market include expanding applications in medical field, rising advantages over other imaging techniques, and technological advancements. The prominent players of the India PET Scan Market are GE Healthcare, Siemens Healthineers, Toshiba, Schiller, Mindray, and Hitachi, among others.
India Genomic Diagnostics Market was valued at $593.77 Mn in 2023 and is predicted to grow at a CAGR of 19.5% from 2023 to 2030, to $2,066.31 Mn by 2030. The key drivers of this industry include increasing prevalence, technological advancements, and government initiatives. The industry is primarily dominated by Illumina, 23andMe, Myriad Genetics, and Amgen among others.
The India Exosome Research Market was valued at $3.1 Mn in 2023 and is projected to grow at a CAGR of 19% from 2023 to 2023, to $10.4 Mn by 2030. The key drivers of this industry are increasing prevalence and incidences of cancer and various auto-immune diseases, rising healthcare expenditure for better health services, growing R&D activities associated with exosome research, technological advancements in exosome isolation and analytical procedures, increasing advanced applications of exosomes. The industry is primarily dominated by players such as ExoDx, Reelabs, Thermo Fisher Scientific, MagGenome, Clevergene Biocorp, Theranosis Life Sciences among others.
The India Mouth Ulcer Therapeutics Market was valued at $27.6 Mn in 2023 and is projected to grow at a CAGR of 6.9% from 2023 to 2023, to $44.1 Mn by 2030. The key drivers of this industry are rising awareness about oral hygiene, increasing demand for rapid healing products, growing geriatric population, rise in tobacco consumption, increasing incidence of oral diseases, chemical-based toothpaste and unhealthy lifestyles etc. The industry is primarily dominated by players such as Cipla, Mylan, Dr Reddy’s, Hetero among others.
The India Bariatric Surgery Devices Market was valued at $48 Mn in 2023 and is projected to grow at a CAGR of 8.2% from 2023 to 2023, to $84 Mn by 2030. Major factors driving the market for bariatric surgical devices include the rising incidence of adult obesity brought on by altered lifestyle patterns and excessive calorie consumption. The demand for bariatric operations is also anticipated to rise over the forecast period due to increased government backing and growing public awareness of the market's unhealthy food and beverage offerings and how they affect BMI, thus driving the market growth of the Bariatric Surgery Devices. The prominent players in the market are Meril Life Sciences, Poly Medicure, Biopore Surgicals, Medtronic, B. Braun, Asenus Surgical, Johnson & Johnson, Cousin Surgery among others.
India CT Scan Market was valued at $83.84 Mn in 2023 and is predicted to grow at a CAGR of 10.87% from 2023 to 2030, to $172.64 Mn by 2030. The key drivers of this industry include the rising burden of chronic diseases, growing population, and increasing healthcare expenditure. The industry is primarily dominated by GE HealthCare, Siemens Healthineers, Canon Medical Systems, and Koninklijke Philips, among others.
The India Lipid Disorder Therapeutics Market was valued at $151.5 Mn in 2023 and is predicted to grow at a CAGR of 12.88% from 2023 to 2030, to $353.8 Mn by 2030. India Lipid Disorder Therapeutics Market is growing due to the Prevalence of cardiovascular diseases, Consumer preference for over-the-counter (OTC) drugs, Advancements in Therapeutics, and Growing Healthcare Expenditure and Infrastructure. The industry is primarily dominated by players such as Sun Pharmaceutical Industries Ltd., Cipla, Lupin, Sanofi, Pfizer, Inc., GlaxoSmithKline plc, Novartis AG, Merck & Co., Inc., Amgen Inc., Takeda Pharmaceutical Company Limited, AbbVie, Inc., Viatris, AstraZeneca PLC, and Dr. Reddys Laboratories Ltd.
The India Bio-implant Market was valued at $1182.1 Mn in 2023 and is predicted to grow at a CAGR of 8.9% from 2023 to 2030, to 2147.1 Mn by 2030. The India Bio-implant Market is growing due to like Rising Incidence of Chronic Diseases, Rising Disposable Income, Increasing Awareness, and Patient Education. The market is primarily dominated by players such as Sahajanand Medical Technologies, Biorad Medisys, Zimmer Biomet, Boston Scientific Corporation, Otto Bock Holding GmbH & Co. KG, and Medtronic plc.
The India Mental Health Apps Market was valued at $112.75 Mn in 2023 and is predicted to grow at a CAGR of 18.2% from 2023 to 2030, to $363.46 Mn by 2030. The key drivers of this industry include government initiatives, reduced stigma, and increasing smartphone penetration. The industry is primarily dominated by players such as Calm, Headspace, Moodfit, and YourDOST among others.
The India Herbal Supplements Market was valued at $95.66 Mn in 2023 and is predicted to grow at a CAGR of 9.2% from 2023 to 2030, to $177.13 Mn by 2030. The key drivers of this industry include growing health awareness, traditional medicine heritage, and rising incidence of chronic disease. The industry is primarily dominated by players such as Himalaya Wellness, Dabur India, Patanjali Ayurved, Zandu Realty, and Amway among others.
India Clinical Nutrition for Chronic Kidney Diseases Market was valued at $28.60 Mn in 2023 and is predicted to grow at a CAGR of 9.03% from 2023 to 2030, to $52.30 Mn by 2030. The key drivers of this industry include rising CKD prevalence, increased awareness, and technological advancements. The industry is primarily dominated by Abbott Nutrition, Pfizer Inc., Bayer AG, and Nestlé Health Science among others.
The India Brugada Syndrome Market was valued at $21.8 Mn in 2023 and is predicted to grow at a CAGR of 10.8% from 2023 to 2030, to $44.7 Mn by 2030. The key drivers of the market include growing prevalence of cardiovascular diseases, advancements in genetic testing, and aging population. The prominent players of the India Brugada Syndrome Market are Intas, Sun Pharmaceuticals, Cipla, Divi's Lab, Dr. Reddy's Laboratories, and Zydus Lifesciences, among others.
India Dental Endodontics Market was valued at $31.80 Mn in 2023 and is predicted to grow at a CAGR of 7.3% from 2023 to 2030, to $52.10 Mn by 2030. The key drivers of this industry include rising awareness of oral health, rising prevalence of dental problems, and technological advancements. The industry is primarily dominated by Coltene, Dentsply Sirona, FKG Dentaire, and Ultradent Products among others.
The India Clinical Nutrition Market was valued at $557.8 Mn in 2023 and is projected to grow at a CAGR of 8.34% from 2023 to 2023, to $977.2 Mn by 2030. The key drivers of this industry are increasing prevalence of chronic diseases and metabolic disorders, aging population, increasing awareness of the importance of nutrition for health, product innovations and technological advancements, government initiatives and rising healthcare expenditure, rising incidence of malnutrition especially in paediatric patients which has contributed to market growth. The industry is primarily dominated by players such as Sun Pharmaceuticals, Zydus Wellness, Glenmark Pharmaceuticals, Zeon Lifesciences, Nestle, Mead Johnson & Company, LLC among others.
The India Biosensors Market was valued at $525.6 Mn in 2023 and is predicted to grow at a CAGR of 11% from 2023 to 2030, to $1091.2 Mn by 2030. The key drivers of the market include increasing burden of chronic diseases, increasing demand for accurate disease diagnosis, and growing demand for Point-of-Care (POC) testing. The prominent players of the India Biosensors Market are i- SENS, SD Biosensor, Fortune Biosolutions, Glowvista Instruments, and Healthium Medtech, among others.